USPTO Examiner KIM SUN U - Art Unit 1777

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18867141DIALYSIS SYSTEM HAVING ENHANCED VALVE FEATURESNovember 2024April 2025Allow500NoNo
18893058PROCESS OF PURIFICATION OF PROTEINSeptember 2024January 2025Allow400NoNo
18824560KITCHEN WASTE WASTEWATER TREATMENT EQUIPMENTSeptember 2024October 2024Allow200NoNo
18805922INTEGRATED RAPID TREATMENT SYSTEM FOR NUCLEAR MEDICAL RADIOACTIVE WASTEWATER AND APPLICATION METHOD THEREOFAugust 2024October 2024Allow200NoNo
18797446SULFUR-MOLYBDENUM CLUSTER MODIFIED MOF MATERIAL AND PREPARATION METHOD AND APPLICATION THEREOFAugust 2024October 2024Allow200NoNo
18756677PRASEODYMIUM-DOPED UPCONVERSION PHOSPHORJune 2024September 2024Allow300NoNo
18747386Outdoor Water PurifierJune 2024September 2024Allow300NoNo
18653906COMPOSITIONS AND METHODS FOR PLASMAPHERESISMay 2024October 2024Allow501NoNo
18653903COMPOSITIONS AND METHODS FOR PLASMAPHERESISMay 2024February 2025Allow920YesNo
18651805SYSTEM AND PROCESS FOR REDUCING PFAS AND MICROPLASTICS IN BIOSOLIDS USING HYDRODYNAMIC CAVITATION AND FOAM FRACTIONATIONMay 2024January 2025Allow901NoNo
18648343Membrane Fouling Early Warning Method and Device Based on Machine LearningApril 2024July 2024Allow300NoNo
18631965FILTER ELEMENT MOUNTING STRUCTUREApril 2024June 2024Allow200NoNo
18619120DEVICE FOR TREATING URANIUM TAILINGS WITH MICROORGANISMMarch 2024July 2024Allow400NoNo
18605528Hemofilter For In Vivo Blood FiltrationMarch 2024February 2025Allow1110NoNo
18595901METHOD AND SYSTEM FOR SUSTAINABLE BRINE TREATMENT AND HEAVY METAL PURIFICATION USING RECYCLED CARBON FIBERMarch 2024August 2024Allow501NoNo
18595191APPARATUS FOR SUPPLEMENTING FUNCTION OF ENDOCRINE GLANDSMarch 2024May 2025Allow1410NoNo
18584581TRI-METALLIC ORGANIC FRAMEWORK (MOF) COMPLEX AS A REDUCTION CATALYSTFebruary 2024June 2024Allow401NoNo
18407456WATER PURIFICATION, STERILIZATION AND DISINFECTION LAMPJanuary 2024April 2024Allow300NoNo
18577901APPARATUS AND PROCESS FOR REMOVING PFAS AND PFAS COMPOUNDS FROM WATERJanuary 2024June 2024Allow500NoNo
18400507ABSOLUTE BLOOD VOLUME ESTIMATION DEVICE AND METHODDecember 2023November 2024Allow1100NoNo
18491072DEVICE FOR FORMING A MEDICAL PASTEOctober 2023August 2024Allow1010NoNo
18287800COMPOSITE SEMIPERMEABLE MEMBRANEOctober 2023July 2024Allow810NoNo
18456122ELECTRICAL PLUG FOR A DIALYSIS MACHINEAugust 2023August 2024Allow1210NoNo
18452516HEMODIALYSIS SYSTEMS AND METHODSAugust 2023April 2024Allow800NoNo
18365090DEVICES FOR EFFICIENT SORBENT UTILIZATION IN LITHIUM EXTRACTIONAugust 2023January 2024Allow600NoNo
18358840BLOOD CIRCUIT ASSEMBLY FOR A HEMODIALYSIS SYSTEMJuly 2023February 2024Allow700NoNo
18224127Treatment Fluid Multi-Stream Blood WarmerJuly 2023August 2024Allow1301NoNo
18219938SYSTEM AND METHOD FOR CARDIOPULMONARY BYPASS USING HYPOBARIC OXYGENATIONJuly 2023February 2024Allow800NoNo
18346174BLOOD TREATMENT SYSTEMS AND METHODSJune 2023July 2024Allow1320NoNo
18269652PERITONEAL DIALYSIS SYSTEM HAVING DISINFECTION FLUID PUMPING AND PATHWAYJune 2023October 2023Allow400NoNo
18211778AUTOMATIC PLASMA SEPARATION AND METERINGJune 2023February 2025Allow2011NoNo
18204305COMPOSITIONS AND METHODS FOR PLASMAPHERESISMay 2023March 2024Allow1011NoNo
18204306COMPOSITIONS AND METHODS FOR PLASMAPHERESISMay 2023August 2024Allow1431YesNo
18204293COMPOSITIONS AND METHODS FOR PLASMAPHERESISMay 2023February 2024Allow911YesNo
18323055Blood Processing Apparatus and Method for Detoxifying Bacterial Lipopolysaccharide In VivoMay 2023April 2024Allow1111NoNo
18323077Blood Processing Apparatus and Method forDestroying Cancer Metastasis In VivoMay 2023April 2024Allow1111NoNo
18200119WEARABLE MODULAR EXTRACORPOREAL LIFE SUPPORT DEVICE FOR MOBILE TREATMENT OF SINGLE AND MULTIORGAN FAILUREMay 2023August 2024Allow1511NoNo
18143733Blood Treatment Device Priming Devices, Methods, and SystemsMay 2023December 2023Allow801NoNo
18138711CASSETTE SYSTEM INTEGRATED APPARATUSApril 2023March 2024Allow1010NoNo
18130635BLOOD PLASMA SEPARATION DEVICEApril 2023November 2023Allow800NoNo
18171637EXTRACORPOREAL BLOOD FILTERING MACHINE AND METHODSFebruary 2023July 2023Allow500NoNo
18171640EXTRACORPOREAL BLOOD FILTERING MACHINE AND METHODSFebruary 2023March 2024Allow1321NoNo
18171636EXTRACORPOREAL BLOOD FILTERING MACHINE AND METHODSFebruary 2023January 2024Allow1120NoNo
18109547SYSTEMS AND METHODS FOR OPTIMIZATION OF PLASMA COLLECTION VOLUMESFebruary 2023June 2023Allow420NoNo
18103458CONTROL SYSTEMS AND METHODS FOR BLOOD OR FLUID HANDLING MEDICAL DEVICESJanuary 2023February 2024Allow1320NoNo
18017619PRESSURE SENSORS, INCLUDING PRESSURE SENSORS FOR AUTOMATED PERITONEAL DIALYSIS SYSTEMS, AND ASSOCIATED SYSTEMS, DEVICES, AND METHODSJanuary 2023July 2025Allow2900NoNo
18094820ULTRAPURE WATER SUPPLY APPARATUS, SUBSTRATE PROCESSING SYSTEM INCLUDING THE SAME, AND SUBSTRATE PROCESSING METHOD USING THE SAMEJanuary 2023August 2024Allow1901NoNo
18081375PERITONEAL DIALYSIS SYSTEM HAVING CARBON DIOXIDE INJECTION TO INHIBIT/REMOVE CALCIUM CARBONATEDecember 2022April 2025Allow2800NoNo
18059181PERITONEAL DIALYSIS SYSTEM AND METHODSNovember 2022November 2023Allow1200NoNo
17927141PERITONEAL DIALYSIS USING PRESSURIZED CHAMBERNovember 2022June 2025Allow3101NoNo
17927135PERITONEAL DIALYSIS USING PRESSURIZED CYLINDERNovember 2022April 2025Allow2800NoNo
17986397Hemofilter For In Vivo Blood FiltrationNovember 2022December 2023Allow1310NoNo
17984408Microfluidic Diffusion Devices And Systems, And Methods Of Manufacturing And Using SameNovember 2022January 2025Allow2620NoNo
17983668PERITONEAL DIALYSIS CYCLER HAVING DISINFECTIONNovember 2022June 2025Allow3101NoNo
17981635PERITONEAL DIALYSIS CYCLER HAVING DISINFECTIONNovember 2022June 2025Allow3101NoNo
17977785Self-Sealing Fluid ConnectorsOctober 2022May 2025Allow3001NoNo
17974364BLOOD TREATMENT SYSTEMS AND METHODSOctober 2022March 2023Allow400NoNo
17974023System for Tailoring Dialysis Treatment Based on Sensed Potassium Concentration, Patient Data, and Population DataOctober 2022October 2023Allow1210NoNo
17920584MEASUREMENT AND AUTOMATED PERITONEAL DIALYSIS APPARATUS AND METHOD THEREFOROctober 2022March 2025Allow2900NoNo
17959147GAS TREATMENT DELIVERY SYSTEMS AND METHODSOctober 2022November 2024Abandon2530NoYes
17943377TECHNIQUES FOR REMOVING BOUND TARGET SUBSTANCES DURING DIALYSISSeptember 2022January 2024Allow1600NoNo
17909013SYSTEM AND METHOD FOR MONITORING SEMICONDUCTOR PROCESSESSeptember 2022November 2024Allow2611NoNo
17905413Extracorporeal oxygenation system for low flow rates and methods of useSeptember 2022March 2023Allow700NoNo
17892973SORBENT FOR A DIALYSIS DEVICE AND DIALYSIS SYSTEMAugust 2022February 2025Allow2912NoNo
17888262BIOLOGICAL FLUID PURIFICATION WITH BIOCOMPATIBLE MEMBRANESAugust 2022October 2023Allow1410NoNo
17797074Connector for Creating Platelet Rich PlasmaAugust 2022May 2024Allow2111YesNo
17873798SYSTEM FOR CONCENTRATING PHOSPHOLIPIDSJuly 2022May 2025Allow3311NoNo
17814539APPARATUS UTILIZING ELECTRIC FIELD FOR PROCESSING OF BLOOD TO NEUTRALIZE PATHOGEN CELLS THEREINJuly 2022March 2025Allow3200NoNo
17788855CRUSHING DEVICE AND WASTE TREATMENT DEVICEJune 2022March 2025Abandon3311NoNo
17843950MODIFIED TNF AS A CAPTURE LIGANDJune 2022February 2024Allow2021NoNo
17838902CUSTOM DATA FIELDS FOR AUTOMATED APHERESIS PROCEDURESJune 2022October 2023Allow1611NoNo
17825918SYSTEMS AND METHODS FOR OPTIMIZATION OF PLASMA COLLECTION VOLUMESMay 2022July 2024Allow2611NoNo
17777590A BIOPROCESS FLUID MIXING SYSTEMMay 2022March 2025Allow3410NoNo
17745161FILTER BOWL RETENTION MECHANISMMay 2022June 2024Allow2510NoNo
17743167SYRINGE-BASED MANUAL EXTRACORPOREAL BLOOD TREATMENT SYSTEMS AND METHODS EMPLOYING BATCH PROCESSINGMay 2022March 2025Allow3410NoNo
17738420AUTOMATED PERITONEAL DIALYSIS SYSTEM HAVING A DRAIN PURGEMay 2022March 2025Allow3400NoNo
17738368AUTOMATED PERITONEAL DIALYSIS SYSTEM HAVING A DISPOSABLE CASSETTE AND VALVE SEAT THEREFOREMay 2022March 2025Allow3400NoNo
17738276AUTOMATED PERITONEAL DIALYSIS SYSTEM HAVING LOAD CELL CALIBRATIONMay 2022February 2025Allow3400NoNo
17737611Membrane System to Treat Leachate and Methods of Treating LeachateMay 2022August 2023Allow1620NoNo
17731054ISOPOROUS SELF-ASSEMBLED BLOCK COPOLYMER FILMS CONTAINING HIGH MOLECULAR WEIGHT HYDROPHILIC ADDITIVES AND METHODS OF MAKING THE SAMEApril 2022June 2023Allow1410NoNo
17716434ELECTRICAL PLUG FOR A MEDICAL DEVICEApril 2022May 2023Allow1410NoNo
17766536PRINTABLE ELECTRICAL COMPONENT COMPRISING A PLASTIC SUBSTRATEApril 2022May 2023Allow1311NoNo
17696546Medicament Preparation Devices, Methods, and SystemsMarch 2022April 2025Allow3701NoNo
17675824SYSTEMS AND METHODS FOR OPTIMIZATION OF PLASMA COLLECTION VOLUMESFebruary 2022May 2022Allow310NoNo
17590890NANOBIOCATALYST AND NANOBIOCATALYTIC MEMBRANEFebruary 2022September 2023Allow2020NoNo
17577248REDUCED LEACHING OF A LIGANDJanuary 2022August 2024Abandon3130NoNo
17626653METHOD FOR CLEANING ELECTROPHORETIC COATING BATHS, AND DEVICE THEREFORJanuary 2022February 2025Allow3700NoNo
17626409Device for Capturing and Removing Magnetic Material From a Flow of MaterialJanuary 2022August 2024Allow3100NoNo
17570906SYSTEM FOR REMOVING UREMIC TOXINS IN DIALYSIS PROCESSESJanuary 2022October 2023Allow2111NoNo
17569738Bone Marrow Adipose Portion Isolation Device and MethodsJanuary 2022October 2024Allow3341NoNo
17568680HEMODIALYSIS SYSTEM WITH DIALYSATE RECYCLINGJanuary 2022June 2023Abandon1730NoNo
17563926PERITONEAL DIALYSIS SYSTEM AND METHOD HAVING INTRAPERITONEAL PRESSURE SENSINGDecember 2021November 2024Allow3500NoNo
17563651Peritoneal Dialysis System with Constant Volume Disposable PumpDecember 2021May 2025Allow4001NoNo
17559792VENTING OR DEGASSING OF FILTER DEVICES AND FILTRATION SYSTEMSDecember 2021April 2024Abandon2821NoNo
17618460CLOG FREE CONDENSATION SYSTEM FOR PYROLYSIS VAPOR OF PET CONTAINING POLYMERDecember 2021November 2024Abandon3510NoNo
17618268METHOD AND DEVICE FOR CONTROLLING MOVEMENT OF MICRO-PARTICLES IN SOLUTION USING ULTRA-HIGH FREQUENCY SOUND WAVEDecember 2021January 2025Allow3711NoNo
17617494SUPERCRITICAL FLUID CHROMATOGRAPH AND SAMPLE SUPPLY METHOD USED IN SUPERCRITICAL FLUID CHROMATOGRAPHDecember 2021June 2025Allow4310YesNo
17617059AMINE SEPARATION METHOD USING LIQUID CHROMATOGRAPHYDecember 2021August 2024Allow3210NoNo
17530087HYDROCARBON FLUID-WATER SEPARATIONNovember 2021May 2023Allow1810NoNo
17527844PORTABLE WATER QUALITY INSTRUMENTNovember 2021March 2023Allow1610NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner KIM, SUN U.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
0
(0.0%)
Examiner Reversed
1
(100.0%)
Reversal Percentile
92.3%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
29
Allowed After Appeal Filing
11
(37.9%)
Not Allowed After Appeal Filing
18
(62.1%)
Filing Benefit Percentile
59.9%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 37.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner KIM, SUN U - Prosecution Strategy Guide

Executive Summary

Examiner KIM, SUN U works in Art Unit 1777 and has examined 963 patent applications in our dataset. With an allowance rate of 82.1%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 31 months.

Allowance Patterns

Examiner KIM, SUN U's allowance rate of 82.1% places them in the 48% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by KIM, SUN U receive 1.50 office actions before reaching final disposition. This places the examiner in the 36% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by KIM, SUN U is 31 months. This places the examiner in the 35% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +8.5% benefit to allowance rate for applications examined by KIM, SUN U. This interview benefit is in the 41% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 31.3% of applications are subsequently allowed. This success rate is in the 56% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 44.8% of cases where such amendments are filed. This entry rate is in the 62% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 111.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 78% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 95.5% of appeals filed. This is in the 84% percentile among all examiners. Of these withdrawals, 52.4% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 50.6% are granted (fully or in part). This grant rate is in the 62% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 4.2% of allowed cases (in the 87% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 8.8% of allowed cases (in the 86% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.